Your browser doesn't support javascript.
loading
Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade.
Hsu, Joy; Hodgins, Jonathan J; Marathe, Malvika; Nicolai, Chris J; Bourgeois-Daigneault, Marie-Claude; Trevino, Troy N; Azimi, Camillia S; Scheer, Amit K; Randolph, Haley E; Thompson, Thornton W; Zhang, Lily; Iannello, Alexandre; Mathur, Nikhita; Jardine, Karen E; Kirn, Georgia A; Bell, John C; McBurney, Michael W; Raulet, David H; Ardolino, Michele.
Afiliação
  • Hsu J; Department of Molecular and Cell Biology, Immunotherapy and Vaccine Research Initiative, Cancer Research Laboratory, Division of Immunology and Pathogenesis, University of California, Berkeley, Berkeley, California, USA.
  • Hodgins JJ; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada.
  • Marathe M; Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
  • Nicolai CJ; Department of Molecular and Cell Biology, Immunotherapy and Vaccine Research Initiative, Cancer Research Laboratory, Division of Immunology and Pathogenesis, University of California, Berkeley, Berkeley, California, USA.
  • Bourgeois-Daigneault MC; Department of Molecular and Cell Biology, Immunotherapy and Vaccine Research Initiative, Cancer Research Laboratory, Division of Immunology and Pathogenesis, University of California, Berkeley, Berkeley, California, USA.
  • Trevino TN; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada.
  • Azimi CS; Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
  • Scheer AK; Department of Molecular and Cell Biology, Immunotherapy and Vaccine Research Initiative, Cancer Research Laboratory, Division of Immunology and Pathogenesis, University of California, Berkeley, Berkeley, California, USA.
  • Randolph HE; Department of Molecular and Cell Biology, Immunotherapy and Vaccine Research Initiative, Cancer Research Laboratory, Division of Immunology and Pathogenesis, University of California, Berkeley, Berkeley, California, USA.
  • Thompson TW; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada.
  • Zhang L; Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
  • Iannello A; Department of Molecular and Cell Biology, Immunotherapy and Vaccine Research Initiative, Cancer Research Laboratory, Division of Immunology and Pathogenesis, University of California, Berkeley, Berkeley, California, USA.
  • Mathur N; Department of Molecular and Cell Biology, Immunotherapy and Vaccine Research Initiative, Cancer Research Laboratory, Division of Immunology and Pathogenesis, University of California, Berkeley, Berkeley, California, USA.
  • Jardine KE; Department of Molecular and Cell Biology, Immunotherapy and Vaccine Research Initiative, Cancer Research Laboratory, Division of Immunology and Pathogenesis, University of California, Berkeley, Berkeley, California, USA.
  • Kirn GA; Department of Molecular and Cell Biology, Immunotherapy and Vaccine Research Initiative, Cancer Research Laboratory, Division of Immunology and Pathogenesis, University of California, Berkeley, Berkeley, California, USA.
  • Bell JC; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada.
  • McBurney MW; Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
  • Raulet DH; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada.
  • Ardolino M; Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
J Clin Invest ; 128(10): 4654-4668, 2018 10 01.
Article em En | MEDLINE | ID: mdl-30198904
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células Matadoras Naturais / Antígeno B7-H1 / Receptor de Morte Celular Programada 1 / Imunoterapia / Neoplasias Experimentais Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células Matadoras Naturais / Antígeno B7-H1 / Receptor de Morte Celular Programada 1 / Imunoterapia / Neoplasias Experimentais Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article